Learning Center

This webinar provides an overview of the evolving landscape of anti-amyloid therapies for Alzheimer's disease. Clinical leaders offer practical considerations and important insights for the implementation of these therapies in clinical settings.

Developed by the Gerontological Society of America (GSA) in collaboration with the Alzheimer’s Association with support from Lilly.  

This webinar highlights how care teams can provide individualized assistance to patients and families on their anti-amyloid therapy journey, with patient navigation serving as a key element in facilitating access, managing care, and ensuring ongoing support. 

Developed by the Gerontological Society of America (GSA) in collaboration with the Alzheimer’s Association with support from Lilly. 

This webinar is dedicated to exploring the crucial topic of expanding access to groundbreaking therapies for Alzheimer's disease to individuals living in rural communities.

Developed by the Gerontological Society of America (GSA) in collaboration with the Alzheimer’s Association with support from Lilly. 

The chronic disease of obesity, combined with age-related changes and other health conditions, results in complexities when managing obesity in women as they age. Interprofessional care teams need a comprehensive, personalized approach, including lifestyle interventions and the availability of a full range of treatment options. This GSA Momentum Discussion webinar, recorded at the GSA 2025 Annual Scientific Meeting, highlights trends in the care of women with obesity as they age.

Support provided by Novo Nordisk and Haleon.

Amyloid-lowering monoclonal antibody (mAb) therapies for early symptomatic Alzheimer’s disease, including mild cognitive impairment and mild dementia, have generated new excitement about the future of treatment for this progressive condition. These treatments aim to slow or halt the progression of Alzheimer's disease by tackling an underlying cause of the disease – not just managing its symptoms. The evidence shows that individuals receiving these therapies can experience slower disease progression and the potential to extend their independence in everyday life.  This GSA Momentum Discussion webinar, recorded at the GSA 2025 Annual Scientific Meeting, highlights the clinical outcomes associated with mAb therapies through the reflections of patients receiving the treatments and those who support them.

Support provided by Eisai.

Older adults often do not obtain adequate amounts of micronutrients from their regular dietary patterns and are at risk for nutritional deficiencies. The risk for inadequate vitamin and mineral intake increases as people age. Supplementation with vitamins and minerals may help older adults meet their nutritional needs but should be guided by healthcare teams. This GSA Momentum Discussion webinar, recorded at the GSA 2025 Annual Scientific Meeting, highlights expert strategies for enhancing nutritional research and incorporating nutritional information into clinical practice guidelines to increase the clinician's confidence around vitamin and mineral recommendations.

Support provided by Haleon.

Despite increasing attention to the opioid crisis, older adults are frequently overlooked in discussions of opioid use and misuse. They are both under-treated for pain and overexposed to opioid-related risks due to polypharmacy, cognitive decline, and fragmented care. This session examines how clinicians and industry stakeholders can respond to the nuanced needs of this population—by promoting appropriate prescribing, improving monitoring, reducing stigma, and expanding access to harm reduction tools.

Support provided by Emergent BioSolutions.

Increased life expectancy is reshaping health care and workforce dynamics, highlighting the impact of chronic health conditions and the shortage of health care professionals. This panel explores actionable strategies to prepare for the challenges and opportunities of an aging population.

Support provided by TIAA Institute.

Despite their health, economic, and societal benefits, vaccine acceptance in the current climate is uncertain. This session will address why older adult vaccination should continue to be a priority to prevent certain illnesses. A multidisciplinary panel will explore the current state of the vaccine landscape.

Support provided by CSL Seqirus, GSK, Johnson & Johnson, Pfizer, and Sanofi.

During this webinar, expert faculty will discuss the strong, bidirectional link between obesity and obstructive sleep apnea (OSA) among aging and older adults. They examine how excess weight contributes to airway collapse and decreased lung volume and how untreated OSA-induced fatigue and hormonal changes may lead to further weight gain. The faculty will highlight heightened risks for comorbidities such as hypertension, cardiovascular disease, type 2 diabetes, and cognitive decline when both conditions are present, and they will review interprofessional treatment approaches aimed at improving health and quality of life for older and aging adults with obesity and OSA. 

Each year, the Alzheimer's Association releases a report outlining the growing dementia crisis in America. Based on the most recent edition of the publication, this webinar will review the burden Alzheimer's and dementia is placing on individuals, caregivers, government, and the nation's health care system. In addition, it will cover new findings from the publication's special report on how Americans view the importance of early detection of Alzheimer's.

This GSA Momentum Discussions Webinar explores the critical role of interdisciplinary collaboration in increasing adult immunization rates. The session brings together healthcare professionals—including nurses, pharmacists, social workers, and public health experts—to discuss strategies for improving vaccine access, education, and adherence among older adults. Panelists highlight the importance of teamwork, cultural considerations, and trust-building in vaccination efforts. Key topics include the evolving role of pharmacy, the contributions of social workers and nurses, and expanding the conversation from individual disease prevention to broader public health and economic benefits. Through interdisciplinary cooperation, healthcare providers can break barriers, improve communication, and enhance vaccination rates to support healthier aging populations.

Support provided by GSK, Johnson & Johnson, Pfizer, Sanofi, and CSL Sequirus.

GSA Momentum Discussions webinar, Family Caregiving at a Tipping Point, explores the evolving role of family caregivers and the support needed through healthcare systems, policies, and technology. Panelists discuss the diversity of caregiving experiences, the importance of recognizing caregivers in healthcare, access to mental health and educational resources, and the role of digital tools in easing caregiving burdens. Topics include data-driven advocacy, evidence-based interventions, reimbursement strategies, and integrating caregivers into care teams. Panelists emphasize personalized solutions, system-level support, and the 4Ms Framework (Medication, Mobility, Mind, and What Matters Most) to enhance caregiver and patient well-being.

This GSA Momentum Discussions webinar, “Addressing Ageism in Healthcare,” is an engaging session designed to raise awareness and drive meaningful change in healthcare education and practice. This critical conversation will explore the widespread impact of age discrimination in medical settings, including its effects on healthcare outcomes, economic costs, and patient well-being. Expert panelists will discuss key topics such as the various forms of ageism in healthcare, its financial and societal consequences, and strategies for change through advocacy, education, and policy reform. Additionally, GSA has introduced its initiative to develop an interdisciplinary curriculum that promotes age-inclusive healthcare.

Support provided by AARP.

The GSA Momentum Discussion webinar, Seven Strategies for Quality Obesity Care for Older Adults, explored critical issues surrounding obesity as a chronic disease and strategies to improve care for older adults. The discussion highlights the need for an evidence-based, interprofessional approach to obesity management. Panelists addressed persistent stigma and bias in healthcare, disparities in access to treatment, and the importance of cultural considerations in obesity care. They also emphasized the necessity of Medicare coverage for comprehensive obesity care and discussed the Treat and Reduce Obesity Act (TROA) as a potential solution. The conversation concluded with a look at emerging innovations and therapies that could enhance quality of life for older adults with obesity.

Support provided by Novo Nordisk.

This GSA Momentum Discussion webinar brought together leading experts to explore how primary care teams can ensure timely and effective referrals for patients with mild cognitive impairment (MCI) and early Alzheimer’s disease. With new disease-modifying therapies emerging, the conversation covered overcoming diagnostic barriers, prioritizing referrals, understanding the safety and efficacy of anti-amyloid treatments, preparing patients for neurology appointments, and addressing their questions about treatment benefits. The discussion also highlighted the importance of interdisciplinary care and referrals to other specialists to support comprehensive cognitive health management. It was an opportunity to gain actionable insights and improve care pathways for individuals with cognitive impairment.

Support provided by Eisai.

This GSA Momentum Discussion webinar brought together a multidisciplinary panel of scientists and healthcare professionals to explore the latest breakthroughs in diagnostics, therapeutics, and risk reduction strategies. This forward-thinking discussion highlighted how innovations like the new CMS GUIDE Model are transforming care for individuals with Alzheimer’s disease and other dementias and their families. Key topics included addressing dementia risk factors, tackling health inequities, advancing blood biomarkers for clinical use, learning from care partners’ lived experiences, and enhancing dementia care delivery through the GUIDE program. The conversation also touched on the impact of anti-amyloid and disease-modifying therapies, innovations in cognitive evaluation, and promising developments on the horizon for Alzheimer’s research, care models, and therapies.

Support provided by the GSA KAER Brain Health Supporters Circle (Eisai, Genentech, Lilly, and Otsuka).

Following the GSA 2024 Momentum Discussion “Learners for Life: The Future of Higher Education in an Era of Longevity” in Seattle, the panel regrouped to film a webinar designed to equip higher education leaders with insights into how to transform their institutions into age-friendly environments that address the educational needs of diverse age groups, making higher education a meaningful space for lifelong learners.

This webinar explores the intersection of aging and education and the opportunities that increased life expectancy presents for higher education. The discussion focuses on how higher education can better accommodate age-diverse learners, ranging from older students returning for degrees to faculty and staff planning for retirement.

Download the transcript

Support provided by TIAA Institute.